Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Odiparcil in Mucopolysaccharidosis VI
NCT03370653Phase 2Completed
- Sponsor
- Inventiva
- Start
- Dec 2017
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of odiparcil in mucopolysaccharidosis type VI, sponsored by Inventiva. Started Dec 2017; status: completed.
02
Drugs
odiparcil
03
Conditions
mucopolysaccharidosis type VI
Beyond the preview
Go deeper on NCT03370653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03370653.